- Home
- KALA vs DTST Comparison
KALA vs DTST Comparison
Compare KALA & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- DTST
- Stock Information
- Founded
- KALA 2009
- DTST 2001
- Country
- KALA United States
- DTST United States
- Employees
- KALA N/A
- DTST N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- DTST EDP Services
- Sector
- KALA Health Care
- DTST Technology
- Exchange
- KALA Nasdaq
- DTST Nasdaq
- Market Cap
- KALA 26.2M
- DTST 28.2M
- IPO Year
- KALA 2017
- DTST N/A
- Fundamental
- Price
- KALA $4.82
- DTST $3.45
- Analyst Decision
- KALA Strong Buy
- DTST
- Analyst Count
- KALA 3
- DTST 0
- Target Price
- KALA $14.00
- DTST N/A
- AVG Volume (30 Days)
- KALA 74.3K
- DTST 34.3K
- Earning Date
- KALA 08-05-2025
- DTST 08-13-2025
- Dividend Yield
- KALA N/A
- DTST N/A
- EPS Growth
- KALA N/A
- DTST N/A
- EPS
- KALA N/A
- DTST 0.02
- Revenue
- KALA N/A
- DTST $25,219,312.00
- Revenue This Year
- KALA N/A
- DTST $12.57
- Revenue Next Year
- KALA N/A
- DTST $9.29
- P/E Ratio
- KALA N/A
- DTST $146.47
- Revenue Growth
- KALA N/A
- DTST N/A
- 52 Week Low
- KALA $2.92
- DTST $2.93
- 52 Week High
- KALA $11.20
- DTST $6.95
- Technical
- Relative Strength Index (RSI)
- KALA 55.88
- DTST 44.74
- Support Level
- KALA $4.36
- DTST $3.33
- Resistance Level
- KALA $5.90
- DTST $3.48
- Average True Range (ATR)
- KALA 0.48
- DTST 0.17
- MACD
- KALA 0.05
- DTST -0.01
- Stochastic Oscillator
- KALA 39.81
- DTST 35.09
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.